I Spent 7 Years Selling Brain Supplements I Knew Were Incomplete. Here's What We Were Hiding.

I worked at one of the top three nootropic companies in America for seven years. I'm not going to name them. I signed an NDA when I left, and I'd like to keep my house.

But I will tell you this.

The morning I quit, I walked through the office one last time and looked at the supplement bottles lining the shelves in our marketing department — the bottles I had personally helped launch — and I knew with absolute certainty that the people taking them were getting almost nothing.

Not because we were lying. Not because we were using bad ingredients. The L-Tyrosine was real. The dosages were accurate. The third-party testing was legitimate.

The problem was something the industry has known for over a decade and refuses to fix — because fixing it would expose every other product on the market as fundamentally incomplete.

I'm writing this because my mother called me last month, struggling to remember the names of her grandchildren. And I realized I couldn't keep my mouth shut anymore.

How I Ended Up Inside The Industry

I came into this category from pharmaceutical marketing. I had spent fifteen years at one of the big pharma companies, mostly working on cardiovascular drugs. I was tired of regulatory oversight. I wanted to work somewhere I could move faster.

The nootropic industry looked like a dream. Premium pricing. Loyal customers. No FDA approval required for general wellness claims. The brand I joined had just closed a Series B round and was scaling fast.

For the first two years, I genuinely believed in what we were selling.

The product was based on L-Tyrosine — the amino acid that everyone in the cognitive enhancement space had built their formulas around. The research backing L-Tyrosine for stress, focus, and mental performance is real. I had read the papers. I had talked to the formulators. The science seemed solid.

Then, in year three, I started reading the customer service logs.

The Pattern Nobody Wanted To Talk About

Customer service logs are gold for a marketer. They tell you what's actually happening with your product in the real world. What customers are saying. What they're feeling. What they're not getting.

What I found, when I started reading our logs carefully, was a pattern I couldn't unsee.

Roughly 60% of our customers reported a noticeable effect in the first week. A bump in focus. A slight lift in mood. Something — anything — that felt like the product was working.

And then, by week three or four, the same customers would write in saying it had "stopped working." That they "didn't feel anything anymore." That they wondered if they were taking a placebo.

Our standard response was scripted. "Individual biochemistry varies. Some customers experience an adjustment period. Try taking it on an empty stomach. Try increasing your dose."

I asked our head chemist about it once, casually, over lunch.

He laughed. Not in a mean way — in a tired way. The way someone laughs when they've been waiting for you to ask the question.

"Of course it stops working," he said. "L-Tyrosine alone can't sustain dopamine production. The brain runs out of the co-factors needed to convert it. We've known this for years."

I asked why we weren't including the co-factors.

He shrugged. "Marketing decision."

The Internal Conversation That Changed Everything

I spent the next six months trying to push for a formula reformulation internally.

I built decks. I cited research. I showed the customer service logs. I argued that if we added the complete dopamine synthesis pathway to our formula — L-Phenylalanine, the full B-vitamin complex, methylated B12, TMG — we would dramatically increase customer retention and lifetime value.

The marketing team disagreed.

The pushback I got, from the head of marketing in a meeting I will never forget, was this:

"L-Tyrosine is our keyword. The biohacker community has been trained for a decade to look for L-Tyrosine. If we change the formula to highlight seven different ingredients, we lose our SEO position, our Amazon ranking, and our influencer channels overnight. We'd be starting from scratch with a more complicated story to tell."

I pointed out that the customers weren't getting results.

The response was: "The customers are buying. Until they stop buying, the formula is working — for us."

I want to be honest about what I did next. I didn't quit that day. I didn't go to the press. I didn't blow the whistle. I went back to my desk and I kept marketing the product.

I told myself the science was complicated, that customers were getting something out of it, that the placebo effect was real and valuable, that I was being naive.

I stayed for four more years.

The Mechanism We Were Hiding

Here is what I learned, and what every chemist in the industry knows, and what almost no consumer is ever told.

Dopamine production isn't one step. It's a chain of seven steps.

L-Phenylalanine and L-Tyrosine are the raw materials. Your brain converts them — through a series of enzymatic reactions — into L-DOPA, and finally into dopamine itself.

But every one of those conversion steps requires a specific co-factor. Vitamin C activates the tyrosine hydroxylase enzyme. Vitamin B6 activates the L-DOPA decarboxylase enzyme. Folate, methylated B12, and TMG regulate the methylation cycle that keeps dopamine production sustainable instead of one-time.

Skip any one of these, and the chain breaks.

The formula I helped market for seven years contained only L-Tyrosine. Sometimes a token amount of B6. That was it.

For the first week or two, customers would feel something — because their brain was processing the extra L-Tyrosine using whatever co-factors it had in reserve. Once those reserves were depleted, the effect stopped.

This is what was happening to our customers. This is what the customer service logs were recording. This is what the chemists knew. This is what we hid from our consumers for seven years.

Adding the co-factors would have cost roughly $3 per bottle in additional ingredient cost. We sold the bottles for $79.

The Phone Call That Made Me Quit

My mother started taking our product last year.

She'd been struggling with memory lapses and what she called "the fog." Her doctor had run some tests. Everything came back normal. She was 67, healthy, mentally sharp her whole life, and suddenly couldn't remember her grandchildren's names in conversation.

She started taking our supplement because she'd seen it on Instagram, in an ad I had helped write.

For three months, she told me she felt nothing.

I knew exactly why.

I had sat in meetings, for seven years, knowing that our formula couldn't deliver what we promised. And I had let my own mother spend $237 over three months on a product that I knew was biologically incapable of helping her.

The morning after she called me to ask, gently, if maybe she should try something else, I walked into HR and gave my notice.

I cleaned out my desk that afternoon. I signed the NDA on the way out. I haven't worked in the supplement industry since.

The Formula That Finally Does It Right

After I left, I started looking — quietly, anonymously, with the knowledge I'd built up over seven years inside the industry — for a brand that was actually formulating the complete dopamine synthesis pathway.

Most of what I found was the same incomplete formula I'd been selling, just with different marketing.

I found one exception.

Olari Dopamine Brain Food was the only formula I came across that contained all seven required compounds at clinical doses.

Pharmaceutical-grade L-Phenylalanine and L-Tyrosine — the amino acid precursors that form the raw material your brain uses to manufacture dopamine.

Vitamin C, B6, and Folate — the three conversion enzymes that activate the chain. Without these, even high-dose L-Tyrosine sits in your bloodstream doing nothing.

Methylated B12 and TMG — the methylation co-factors that keep dopamine production sustainable instead of one-time. Not the cheap synthetic cyanocobalamin the rest of the industry uses. The bioavailable methylcobalamin form your brain can actually use.

I checked the formulation. I checked the dosing. I checked the manufacturer. It was clean.

I sent my mother a bottle.

What Happened To My Mother

This isn't a stimulant. It's not a "smart drug." It's the actual raw material her brain had been starved of, finally delivered with all the co-factors needed to use it.

Once her brain had what it needed, it did what it was always supposed to do.

Why I'm Telling You This Now

I'm not getting paid to write this. I'm not affiliated with Olari. I'm violating my NDA, in spirit if not in letter, by being this specific about what the inside of the industry looks like.

I'm doing it anyway because I spent seven years selling people products I knew couldn't help them. I let my own mother be one of those people. And I think the customers who are sitting at home right now, three months into a "premium" nootropic brand, wondering why they don't feel anything — they deserve to know the truth.

The industry will not fix itself. The brands I worked for, and the ones competing with them, have built their entire business model on the keyword they refuse to let go of. They'd rather coach customer service to blame your biochemistry than admit their formula is missing six compounds.

You don't have to keep buying it.

What Other Customers Say

You Were Sold An Incomplete Formula. You Don't Have To Buy It Again.

The industry will keep selling you what they've always sold you. The keyword. The promise. The bottle that does just enough to feel like something for a week.

You don't have to keep playing that game.

The complete pathway exists. The science is settled. The only question left is whether you're done blaming yourself.

Start Your Restoration →